Skip to main content

"a 50" Pill Images

The following drug pill images match your search criteria.

Results 375 - 391 of 879 for "a 50"
Pill WraSer 10/500 White Oval is Xolox

WraSer 10/500

Xolox
Strength
500 mg / 10 mg
Imprint
WraSer 10/500
Color
White
Shape
Oval
View details
Pill SCHWARZ 505 Orange Oval is Lactrase

SCHWARZ 505

Lactrase
Strength
250 mg
Imprint
SCHWARZ 505
Color
Orange / White
Shape
Oval
View details
Pill WATSON 491 150 mg Brown Capsule/Oblong is Mexiletine Hydrochloride

WATSON 491 150 mg

Mexiletine Hydrochloride
Strength
150 mg
Imprint
WATSON 491 150 mg
Color
Brown
Shape
Capsule/Oblong
View details
Pill WATSON 493 250 mg Brown Capsule/Oblong is Mexiletine Hydrochloride

WATSON 493 250 mg

Mexiletine Hydrochloride
Strength
250 mg
Imprint
WATSON 493 250 mg
Color
Brown / Green
Shape
Capsule/Oblong
View details
Pill 250 par Yellow Capsule/Oblong is Fluoxetine Hydrochloride and Olanzapine

250 par

Fluoxetine Hydrochloride and Olanzapine
Strength
25 mg / 6 mg
Imprint
250 par
Color
Yellow
Shape
Capsule/Oblong
View details
Pill APO NAB500 White Capsule/Oblong is Nabumetone

APO NAB500

Nabumetone
Strength
500 mg
Imprint
APO NAB500
Color
White
Shape
Capsule/Oblong
View details
Pill a 750 Orange Capsule/Oblong is Niacin Extended-Release
1 / 2
Loading

a 750

Niacin Extended-Release
Strength
750 mg
Imprint
a 750
Color
Orange
Shape
Capsule/Oblong
View details
Pill ENA 50 Yellow Oval is Idhifa

ENA 50

Idhifa
Strength
50 mg
Imprint
ENA 50
Color
Yellow
Shape
Oval
View details
Pill ANCOBON 250 ICN Gray Capsule/Oblong is Flucytosine

ANCOBON 250 ICN

Flucytosine
Strength
250 mg
Imprint
ANCOBON 250 ICN
Color
Gray / Green
Shape
Capsule/Oblong
View details
Pill RAN 150 Brown Capsule/Oblong is Ranitidine Hydrochloride

RAN 150

Ranitidine Hydrochloride
Strength
150 mg
Imprint
RAN 150
Color
Brown
Shape
Capsule/Oblong
View details
Pill FE 400 ALV550 White Capsule/Oblong is Felbamate

FE 400 ALV550

Felbamate
Strength
400 mg
Imprint
FE 400 ALV550
Color
White
Shape
Capsule/Oblong
View details
Pill NA250 White Oval is Abiraterone Acetate

NA250

Abiraterone Acetate
Strength
250 mg
Imprint
NA250
Color
White
Shape
Oval
View details
Pill APO PEN 250 White Capsule/Oblong is Penicillamine
1 / 2
Loading

APO PEN 250

Penicillamine
Strength
250 mg
Imprint
APO PEN 250
Color
White
Shape
Capsule/Oblong
View details
Pill A 250 Purple Oval is Abiraterone Acetate

A 250

Abiraterone Acetate
Strength
250 mg
Imprint
A 250
Color
Purple
Shape
Oval
View details
Pill ALM 750 Yellow Oval is Gralise

ALM 750

Gralise
Strength
750 mg
Imprint
ALM 750
Color
Yellow
Shape
Oval
View details
Pill APO OX150 Yellow Oval is Oxcarbazepine Extended-Release

APO OX150

Oxcarbazepine Extended-Release
Strength
150 mg
Imprint
APO OX150
Color
Yellow
Shape
Oval
View details
Pill ANTABUSE 250 A White Eight-sided is Antabuse

ANTABUSE 250 A

Antabuse
Strength
250 mg
Imprint
ANTABUSE 250 A
Color
White
Shape
Eight-sided
View details

Can't find what you're looking for?

How to use the pill identifier
  1. Enter the imprint code that appears on the pill. Example: L484
  2. Select the the pill color (optional).
  3. Select the shape (optional).
  4. Alternatively, search by drug name or NDC code using the fields above.

Tip: Search for the imprint first, then refine by color and/or shape if you have too many results.

Pill has a logo or symbol?
  • Ignore the logo and type in any other letters or numbers into the imprint search. To refine your results further, add the word "logo" in place of the logo.
  • View our logo identification page for common manufacturer imprints and logos.
No imprint code?

All prescription and over-the-counter (OTC) drugs in the U.S. are required by the FDA to have an imprint code. If your pill has no imprint it could be a vitamin, diet, herbal, or energy pill, or an illicit or foreign drug. It is not possible to accurately identify a pill online without an imprint code.

Learn more about imprint codes.

Search again

Use the pill finder to identify medications by visual appearance or medicine name.

Search by drug name

Search by NDC Code

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.